Table of Contents Author Guidelines Submit a Manuscript
International Journal of Analytical Chemistry
Volume 2011, Article ID 138628, 8 pages
http://dx.doi.org/10.1155/2011/138628
Research Article

Titrimetric and Spectrophotometric Assay of Oxcarbazepine in Pharmaceuticals Using N-Bromosuccinimide and Bromopyrogallol Red

Department of Chemistry, University of Mysore, Manasagangothri, Mysore-570 006, Karnataka, India

Received 13 January 2011; Accepted 4 May 2011

Academic Editor: Mohamed Abdel-Rehim

Copyright © 2011 Nagaraju Rajendraprasad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Grant and D. Faulds, “Oxcarbazepine: a review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders,” Drugs, vol. 43, no. 6, pp. 873–888, 1992. View at Google Scholar · View at Scopus
  2. A. D. Fraser, “New drugs for the treatment of epilepsy,” Clinical Biochemistry, vol. 29, no. 2, pp. 97–110, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. M. M. Kalis and N. A. Huff, “Oxcarbazepine, an antiepileptic agent,” Clinical Therapeutics, vol. 23, no. 5, pp. 680–700, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Musenga, M. A. Saracino, G. Sani, and M. A. Raggi, “Antipsychotic and antiepileptic drugs in bipolar disorder: the importance of therapeutic drug monitoring,” Current Medicinal Chemistry, vol. 16, no. 12, pp. 1463–1481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Juenke, P. I. Brown, F. M. Urry, and G. A. McMillin, “Drug monitoring and toxicology: a procedure for the monitoring of oxcarbazepine metabolite by HPLC-UV,” Journal of Chromatographic Science, vol. 44, no. 1, pp. 45–48, 2006. View at Google Scholar · View at Scopus
  6. M. L. Qi, P. Wang, L. J. Wang, and R. N. Fu, “LC method for the determination of oxcarbazepine in pharmaceutical preparations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 31, no. 1, pp. 57–62, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. K. S. Rao, N. Belorkar, and M. E. B. Rao, “Development and validation of stability-indicating liquid chromatographic method for the quantitative determination of oxcarbazepine in tablet dosage forms,” Journal of Young Pharmacists, vol. 1, no. 3, pp. 270–277, 2009. View at Google Scholar
  8. E. Greiner-Sosanko, S. Giannoutsos, D. R. Lower, M. A. Virji, and M. D. Krasowski, “Drug monitoring: simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetam,” Journal of Chromatographic Science, vol. 45, no. 9, pp. 616–622, 2007. View at Google Scholar · View at Scopus
  9. T. S. Reddy and P. S. Devi, “Validation of a high-performance thin-layer chromatographic method with densitometric detection for quantitative analysis of two anticonvulsants in tablets,” Journal of Planar Chromatography—Modern TLC, vol. 20, no. 6, pp. 451–456, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ivanova, E. Marziali, M. A. Raggi, and E. Kenndler, “Microemulsion electrokinetic chromatography for the separation of carbamazepine, oxcarbazepine, and their metabolites,” Journal of Separation Science, vol. 25, no. 14, pp. 863–871, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Marziali, M. A. Raggi, N. Komarova, and E. Kenndler, “Octakis-6-sulfato-γ-cyclodextrin as additive for capillary electrokinetic chromatography of dibenzoazepines: carbamazepine, oxcarbamazepine and their metabolites,” Electrophoresis, vol. 23, no. 17, pp. 3020–3026, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. E. B. Calvo, O. D. Renedo, and M. J. A. Martínez, “Determination of oxcarbazepine by square wave adsorptive stripping voltammetry in pharmaceutical preparations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 3, pp. 1156–1160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Domínguez-Renedo, M. E. B. Calvo, M. A. Alonso-Lomillo, and M. J. Arcos-Martínez, “Oxcarbazepine analysis by adsorptive stripping voltammetry using silver nanoparticle-modified carbon screen-printed electrodes,” Sensor Letters, vol. 8, no. 2, pp. 268–272, 2010. View at Publisher · View at Google Scholar
  14. B. Paw and K. Woś, “Development and validation of a capillary electrophoresis method for determination of oxcarbazepine and zonisamide in pharmaceuticals,” Journal of Pre-Clinical and Clinical Research, vol. 2, no. 2, pp. 157–159, 2008. View at Google Scholar
  15. B. G. Gowda, M. B. Melwanki, and J. Seetharamappa, “Spectrophotometric determination of certain vicinal dihydroxybenzene derivatives in pharmaceutical preparations,” Analytical Sciences, vol. 17, no. 4, pp. 533–534, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. K. C. Ramesh, B. G. Gowda, M. B. Melwanki, J. Seetharamappa, and J. Keshavayya, “Extractive spectrophotometric determination of antiallergic drugs in pharmaceutical formulations using bromopyrogallol red and bromothymol blue,” Analytical Sciences, vol. 17, no. 9, pp. 1101–1103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. B. G. Gowda, M. B. Melwanki, and J. Seetharamappa, “Extractive spectrophotometric determination of ceterizine HCl in pharmaceutical preparations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 25, no. 5-6, pp. 1021–1026, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. B. S. Nagaralli, J. Seetharamappa, and M. B. Melwanki, “Sensitive spectrophotometric methods for the determination of amoxycillin, ciprofloxacin and piroxicam in pure and pharmaceutical formulations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 29, no. 5, pp. 859–864, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Gandhimathi and T. K. Ravi, “Use of Folin-Ciocalteu phenol reagent and 3-methyl-2-benzothiazolinone hydrazine hydrochloride in the determination of oxcarbazepine in pharmaceuticals,” Acta Pharmaceutica, vol. 58, no. 1, pp. 111–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. S. Ramaa, P. P. Chothe, A. A. Naik, and V. J. Kadam, “Spectrophotometric method for the estimation of oxcarbazepine in tablets,” Indian Journal of Pharmaceutical Sciences, vol. 68, no. 2, pp. 265–266, 2006. View at Google Scholar · View at Scopus
  21. M. A. Sathish and G. Nagendrappa, “Spectrophotometric determination of oxcarbazepine in pharmaceutical formulations,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 2, no. 3, pp. 93–98, 2010. View at Google Scholar
  22. M. Hudlicky, Preparatvni Reakce v Organicke Chemii II, Halogenace a Dehalogenace, NCSAV, Prague, Czech Republic, 1955.
  23. “ICH harmonised tripartite guideline, validation of analytical procedures: text and methodology Q2(R 1),” in Proceedings of the International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, London, UK, November 2005.
  24. J. Inczedy, T. Lengyel, and A. M. Ure, IUPAC Compendium of Analytical Nomenclature: Definitive Rules, Blackwell Science, Boston, Mass, USA, 1998.